A prime example of this process can be seen in patients with gain-of-function mutations in STING who suffer severe systemic inflammation, skin vasculopathy, broad interstitial lung disease, and recurrent bacterial infection, collectively termed STING-associated vasculopathy with onset in infancy (SAVI) [8]. This evidence concerns the gene STING1 and STING-associated vasculopathy with onset in infancy.